AHA GUIDELINES Bundle (free trial)

Atrial Fibrillation 2023 Update

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/387790

Contents of this Issue

Navigation

Page 63 of 131

64 Management Figure 15. Flowchart: Management of Periprocedural Anticoagulation in Patients With AF Patients with AF undergoing invasive procedure or surgery Resumption of anticoagulation the day after low bleeding risk surgery and between the evening of the second day and the evening of the third day after high bleeding risk surgery (2a) Procedure cannot be performed safely on uninterrupted anticoagulation Timing of interruption of DOAC should be guided by the specific agent, renal function, and the bleeding risk (1) Bridging with low- molecular-weight heparin should not be administered (except in patients with mechanical valve or recent stroke or TIA) (3: Harm) Temporary cessation of oral anticoagulation without bridging is recommended (excluding those with recent stroke or TIA, or a mechanical valve) (1) Holding warfarin

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Atrial Fibrillation 2023 Update